Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
Boehringer Ingelheim
Chubb
UBS
Fish and Richardson
US Department of Justice
Merck
AstraZeneca

Generated: December 18, 2018

DrugPatentWatch Database Preview

RADICAVA Drug Profile

« Back to Dashboard

Which patents cover Radicava, and what generic alternatives are available?

Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. There is one patent protecting this drug.

This drug has seven patent family members in six countries.

The generic ingredient in RADICAVA is edaravone. One supplier is listed for this compound. Additional details are available on the edaravone profile page.

Drug patent expirations by year for RADICAVA
Generic Entry Opportunity Date for RADICAVA
Generic Entry Date for RADICAVA*:
Constraining patent/regulatory exclusivity:
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
NDA:
Dosage:
SOLUTION;IV (INFUSION)

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for RADICAVA
(MCI-186)
1-Fenyl-3-methyl-2-pyrazolin-5-on
1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]
1-PEHNYL-3-METHYL-5-PYRAZALONE
1-Phenyl-3-methyl-2-pyrazolin-5-on
1-Phenyl-3-methyl-5-oxo-2-pyrazoline
1-Phenyl-3-methyl-5-pyrazolone
1-Phenyl-3-methylpyrazolone
1-Phenyl-3-methylpyrazolone-5
115566-83-1
12235-58-4
2 4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
2-Pyrazolin-5-one, 3-methyl-1-phenyl-
2,?4-?DIHYDRO-?5-?METHYL-?2-?PHENYL-?3H-?PYRAZOL-?3-?ONE
2,4-dihydro-2-phenyl-5-methyl-3H-pyrazol-3-one
2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
206195-95-1
3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one
3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE
3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE (MCI-186)
3-methyl-1-phenyl-2-pyrazolin-5one
3-Methyl-1-phenyl-2-pyrazoline-5-one
3-Methyl-1-phenyl-2-pyrazoline-5-one, 99%
3-Methyl-1-phenyl-2-pyrazoline-5-one, JIS special grade
3-Methyl-1-phenyl-2-pyrazoline-5-one, purum, >=98.0% (NT)
3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one
3-Methyl-1-phenyl-5-pyrazolone
3-Methyl-1-phenylpyrazol-5-one
3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-
3H-Pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-
4CA-0486
4E-901
5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone)
5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one #
5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one
5-methyl-2-phenyl-2,4-dihydropyrazol-3-one
5-methyl-2-phenyl-4H-pyrazol-3-one
5-Pyrazolone, 3-methyl-1-phenyl-
52224-17-6
62495-97-0
72134-66-8
89-25-8
AB00375776_14
AB00375776_15
AB2000046
AC-4745
AC1L1H8H
AC1Q2PHG
AC1Q6EYP
ACT07289
AE-641/00371017
AI3-03557
AJ-70469
AK128848
AKOS000313817
AM20060748
AN-11638
Antipyrine Related Compound A, United States Pharmacopeia (USP) Reference Standard
BB_SC-0469
BBL011741
BC205186
BCBcMAP01_000127
BCP9000635
BCPP000246
Bio1_000438
Bio1_000927
Bio1_001416
Bio2_000448
Bio2_000928
BRD-K35458079-001-04-2
BRN 0609575
BSPBio_001235
BSPBio_002601
C.I. Developer 1
C13008
CAS-89-25-8
CCG-39352
CCRIS 512
CDS1_000986
CHEBI:31530
CHEMBL290916
CI Developer 1
CS-1832
CTK3E8611
D01552
D06DLI
DB-002517
DB12243
Developer Z
DivK1c_001018
DivK1c_002026
DSSTox_CID_1130
DSSTox_GSID_21130
DSSTox_RID_75961
DTXSID9021130
EC 201-891-0
edarabone
edaravone
Edaravone (JAN/INN)
Edaravone (JP17/INN)
Edaravone (MCI-186)
Edaravone [INN]
Edaravone [USAN:INN]
edaravone and MCI-186 and PMP
edaravone(jan)
EINECS 201-891-0
F0391-0021
FT-0608243
HE022085
HE146249
HMS1362M17
HMS1792M17
HMS1990M17
HMS2234M19
HMS3266F04
HMS3403M17
HMS3654L15
HMS503K17
HMS557M18
HSDB 4102
HY-B0099
I01-2810
IDI1_001018
IDI1_002203
IN1263
InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H
KB-183502
KBio1_001018
KBio2_000575
KBio2_000747
KBio2_003143
KBio2_003315
KBio2_005711
KBio2_005883
KBio3_001029
KBio3_001030
KBio3_001821
KBioGR_000575
KBioGR_001502
KBioSS_000575
KBioSS_000747
KS-00000X6I
KSC448M1D
LS-1892
M0687
Maybridge1_005738
MCI 186
MCI-186
MCI-186, Radicut, 89-25-8
Methylphenylpyrazolone
MFCD00003138
MLS000069602
MLS001146878
MLS002415675
MLS006011753
MolPort-000-182-197
Monopyrazolone
NCGC00018218-01
NCGC00018218-02
NCGC00018218-03
NCGC00018218-04
NCGC00018218-05
NCGC00018218-06
NCGC00018218-07
NCGC00018218-08
NCGC00018218-10
NCGC00022665-02
NCGC00022665-04
NCGC00022665-05
NCGC00022665-06
NCGC00164015-01
NCGC00256515-01
NCGC00259296-01
NCI-C03952
NE10266
NINDS_001018
Norantipyrine
Norphenazone
NSC 12
NSC-12
NSC-26139
NSC-2629
NSC-758622
NSC26139
NSC2629
NSC758622
Opera_ID_1057
Pharmakon1600-01503635
Phenazone impurity A, European Pharmacopoeia (EP) Reference Standard
Phenyl methyl pyrazolone
Phenylmethylpyrazolone
PubChem13301
Q-200386
QELUYTUMUWHWMC-UHFFFAOYSA-N
Radicava (TN)
Radicut
Radicut (TN)
Radicut;MCI-186
RL05601
RTR-028045
s1326
S798V6YJRP
SBI-0051836.P002
SC-13582
SCHEMBL4704
SMR000059020
SPBio_001508
Spectrum_000267
SPECTRUM1503635
Spectrum2_001574
Spectrum3_000971
Spectrum4_001091
Spectrum5_001217
SR-01000000135
SR-01000000135-2
ST012744
ST2410773
STK201315
Tocris-0786
Tox21_112077
Tox21_112077_1
Tox21_201747
Tox21_302819
TR-028045
UNII-S798V6YJRP
WLN: T5NMV DHJ BR& E1
Z50145861
ZINC18203737

US Patents and Regulatory Information for RADICAVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cantor Fitzgerald
Boehringer Ingelheim
Chubb
UBS
Fish and Richardson
US Department of Justice
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.